fentanyl has been researched along with Hyaline Membrane Disease in 2 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of low dose fentanyl infusion analgesia on behavioural and neuroendocrine stress response and short term outcome in premature infants ventilated for hyaline membrane disease." | 9.08 | Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease. ( Agosto, C; Benini, F; Lago, P; Zacchello, F, 1998) |
| "To evaluate the effects of low dose fentanyl infusion analgesia on behavioural and neuroendocrine stress response and short term outcome in premature infants ventilated for hyaline membrane disease." | 5.08 | Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease. ( Agosto, C; Benini, F; Lago, P; Zacchello, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lago, P | 1 |
| Benini, F | 1 |
| Agosto, C | 1 |
| Zacchello, F | 1 |
| Arnold, JH | 1 |
| Truog, RD | 1 |
| Scavone, JM | 1 |
| Fenton, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Stress Assessment in Preterm Infants With Respiratory Distress Syndrome Treated or Not With an Analgesic Drug During the Traditional or the Less Invasive Method of Surfactant Therapy.[NCT04073173] | Phase 4 | 80 participants (Anticipated) | Interventional | 2020-11-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fentanyl and Hyaline Membrane Disease
| Article | Year |
|---|---|
Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease.
Topics: Analgesics, Opioid; Drug Administration Schedule; Female; Fentanyl; Humans; Hyaline Membrane Disease | 1998 |
1 other study available for fentanyl and Hyaline Membrane Disease
| Article | Year |
|---|---|
Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion.
Topics: Extracorporeal Membrane Oxygenation; Female; Fentanyl; Humans; Hyaline Membrane Disease; Infant, New | 1991 |